Heron Therapeutics Inc
|Market Cap (Intraday)||324.87M|
|2yr Forward PE||N/A|
Heron Therapeutics Inc Stock, NASDAQ:HRTX
Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.